Business Context and Reporting Period
This Form 6-K filing by Aegon Ltd., dated May 8, 2026, reports the final results of tender offers for five series of subordinated notes. Aegon is an international financial services holding company headquartered in Schiphol, the Netherlands, and domiciled in Bermuda. The filing covers the period ending May 7, 2026, the expiration deadline for the offers.
Key Financial Metrics and Transaction Details
The company announced the acceptance of valid tenders for a total notional amount of approximately EUR 380 million (USD 447 million equivalent). The aggregate cash amount for the purchase is EUR 308.2 million (USD 363.0 million equivalent). The transaction is expected to generate an IFRS book gain of approximately EUR 0.1 billion in the first half of 2026.
| Note Series | Accepted Nominal Amount | Purchase Price (% of Par) | Outstanding Principal Post-Settlement |
|---|---|---|---|
| 2004 EUR Notes | EUR 106,887,200 | 80.25% | EUR 413,918,500 |
| 2004 USD Notes | USD 136,318,500 | 78.75% | USD 363,681,500 |
| 1995 NLG Notes | NLG 125,270,000 | 89.625% | NLG 124,730,000 |
| Oct 1996 NLG Notes | NLG 82,630,000 | 81.50% | NLG 217,370,000 |
| Feb 1996 NLG Notes | NLG 137,935,000 | 75.00% | NLG 312,065,000 |
The filing does not provide specific figures for total revenue, net profit, operating cash flow, or overall debt levels for the reporting period, as the document focuses exclusively on the tender offer results.
Material Changes and Impact
The primary material change is the reduction of outstanding subordinated debt through the tender offers. The transaction is anticipated to result in a 2 percentage point decrease in the Group solvency ratio, bringing the estimated ratio to approximately 182% (down from an estimated 184% as of December 31, 2025). The settlement date for the accepted notes is expected to be May 11, 2026.
Outlook, Risks, and Contingencies
Management expects a one-time IFRS book gain of EUR 0.1 billion in the first half of 2026. The filing includes extensive forward-looking statements and risk disclosures, including:
- Capital and Solvency: Risks related to maintaining capital adequacy under Solvency II and Bermuda regulations, and the impact of the transaction on the solvency ratio.
- Market Risks: Exposure to volatility in credit, equity, and interest rates, as well as currency exchange rate fluctuations (EUR/USD, EUR/GBP).
- Operational and Strategic Risks: Uncertainty regarding the planned relocation of the company's legal domicile and head office to the United States, including timing and regulatory approval.
- General Risks: Geopolitical tensions, inflation, changes in customer behavior, and potential failures of reinsurers.
Key Facts for Investor Verification
- Verify the actual impact on the Group solvency ratio post-settlement compared to the estimated 2 percentage point decrease.
- Confirm the realization of the projected EUR 0.1 billion IFRS book gain in the H1 2026 financial results.
- Monitor progress and regulatory approvals regarding the planned relocation of the legal domicile to the United States.
- Review the updated outstanding principal amounts for the five note series following the May 11, 2026 settlement.
- Assess the company's liquidity position given the cash outflow of approximately EUR 308 million for the tender offers.